Bill Oxford The market has seen a huge sector rotation recently out of Big Tech and Magnificent Seven stocks into the Dow components, and small and mid-cap stocks. The SPDR® S&P Biotech ETF (XBI) has been the beneficiary of this move. Over the last month, this small/mid-cap biotech ETF has spurted ahead by some 10% while money has come out of the likes of Alphabet Inc. (GOOG), Nvidia Corporation (NVDA) and Microsoft (MSFT). Seeking Alpha If the rally in small and mid-cap biotech equities continues, here ...